Generated Narrative: Composition 30551ce1-5a28-4356-b684-1e639094ad4d identifier: urn:oid:2.16.724.4.8.10.200.10/3f69e0a5-2177-4540-baab-7a5d0877428f status: Final type: Patient summary Document date: 2017-12-11 14:30:00+0100 author: Practitioner Beetje van Hulp title: Patient Summary as of December 11, 2017 14:30 confidentiality: normal attester mode: Legal time: 2017-12-11 14:30:00+0100 party: Practitioner Beetje van Hulp attester mode: Legal time: 2017-12-11 14:30:00+0100 party: Organization Anorg Aniza Tion BV / The best custodian ever custodian: Organization Anorg Aniza Tion BV / The best custodian ever RelatesTos - Code Target[x] * Appends urn:oid:2.16.724.4.8.10.200.10/c2277753-9f90-4a95-8ddb-a0b3f6e7d292 Events - Code Period * care provision ?? --> 2017-12-11 14:30:00+0100
Patient Summary as of December 11, 2017 14:30
Hot flushes
Medication Strength Form Dosage Comment Anastrozole 1 mg tablet once daily treatment for breast cancer Black Cohosh Extract pil herbal supplement
Allergies and adverse reactions Document
Allergy to penicillin, high criticality, active No known food allergies
Breast cancer Stage II with no evidence of recurrence following treatment
Continue hormone medication with Anastrozole for total of 5 years and monitor for potential breast cancer recurrence
Relevant diagnostic tests/laboratory data note
Blood typing Blood group A+ C Ab [Presence] in Serum or Plasma Positive E Ab [Presence] in Serum or Plasma Positive Little c Ab [Presence] in Serum or Plasma Negative Hemoglobin A1c monitoring Hemoglobin A1c/Hemoglobin.total in Blood by HPLC 7.5 % Bacteriology Methicillin resistant Staphylococcus aureus Healthy carrier of MRSA
Marie Lux-Brennard (Apr 17, 1998) Vaccin anti diphtérie-coqueluche-tétanos-poliomyélite, Jun 3, 1998, 10:00:00 PM Voie intramusculaire, Cuisse droite
Generated Narrative: Patient 2b90dd2b-2dab-4c75-9bb9-a355e07401e1-with-immunization Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) Active: true Contact Detail +31788700800 Laan Van Europa 1600 Dordrecht 3317 DB NL mother: Martha Mum Promenade des Anglais 111 Lyon 69001 FR +33-555-20036
Generated Narrative: Practitioner 1c616b24-3895-48c4-9a02-9a64110351ef-with-immunization identifier: urn:oid:2.16.528.1.1007.3.1/129854633 active: true name: Beetje van Hulp Qualifications - Code * Doctor of Medicine
Generated Narrative: Organization 890751f4-2924-4636-bab7-efffc7f3cf15-with-immunization identifier: urn:oid:2.16.528.1.1007.3.3/564738757 active: true name: Anorg Aniza Tion BV / The best custodian ever telecom: +31-51-34343400 address: Houttuinen 27 Dordrecht 3311 CE NL (work)
Anorg Aniza Tion BV / The best custodian ever
Generated Narrative: Condition c64139e7-f02d-409c-bf34-75e8bf23bc80-with-immunization identifier: urn:oid:1.2.3.999/c87bf51c-e53c-4bfe-b8b7-aa62bdd93002 clinicalStatus: Active verificationStatus: Confirmed category: Problem severity: Moderate severity code: Menopausal flushing (finding) subject: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) onset: 2015 recordedDate: 2016-10
Menopausal and female climacteric states
Generated Narrative: MedicationStatement c220e36c-eb67-4fc4-9ba1-2fabc52acec6-with-immunization identifier: urn:oid:1.2.3.999/b75f92cb-61d4-469a-9387-df5ef70d25f0 status: Active medication: Medication Product containing anastrozole (medicinal product) subject: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) effective: 2015-03 --> (ongoing) dosage timing: Count 1 times, Once route: Oral use DoseAndRates - Dose[x] * 1 tablet (Details: UCUM code1 = '1')
Generated Narrative: MedicationStatement 47524493-846a-4a26-bae2-4ab03e60f02e-with-immunization identifier: urn:oid:1.2.3.999/9e312d6b-c6b6-439a-a730-6efaa5dcf8bc status: Active medication: Medication Cimicifuga racemosa extract (substance) subject: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) effective: 2016-01 --> (ongoing) Dosages - Route * Oral use
Generated Narrative: Medication 976d0804-cae0-45ae-afe3-a19f3ceba6bc-with-immunization code: Product containing anastrozole (medicinal product)
Product containing anastrozole (medicinal product)
Generated Narrative: Medication 8adc0999-9468-4ac9-9557-680fa133d626-with-immunization code: Black Cohosh Extract herbal supplement
Generated Narrative: AllergyIntolerance 72884cad-ebe6-4f43-a51a-2f978275f132-with-immunization identifier: urn:oid:1.2.3.999/3a462598-009c-484a-965c-d6b24a821424 clinicalStatus: Active verificationStatus: Confirmed type: Allergy category: Medication criticality: High Risk code: Substance with penicillin structure (substance) patient: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) onset: 2010
Substance with penicillin structure (substance)
Generated Narrative: Condition c4597aa2-688a-401b-a658-70acc6de28c6-with-immunization identifier: urn:oid:1.2.3.999/66d4a8c7-9081-43e0-a63f-489c2ae6edd6 clinicalStatus: Remission verificationStatus: Confirmed category: Problem severity: Severe code: Malignant tumor of breast subject: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) onset: 2015-01 abatement: 2015-03
Borstkanker stadium II zonder aanwijzingen van recidieven na behandeling
Generated Narrative: Organization 45a5c5b1-4ec1-4d60-b4b2-ff5a84a41fd7-with-immunization active: true name: Laboratoire de charme
Generated Narrative: Observation aa11a2be-3e36-4be7-b58a-6fc3dace2741-with-immunization status: Final category: Laboratory code: ABO and Rh group [Type] in Blood subject: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) effective: 2015-10-10 09:15:00+0100 performer: Organization Laboratoire de charme value: Blood group A Rh(D) positive
Generated Narrative: Observation 6e39ccf3-f997-4a2b-8f28-b4b71c778c70-with-immunization status: Final category: Laboratory code: C Ab [Presence] in Serum or Plasma subject: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) effective: 2015-10-10 09:35:00+0100 performer: Organization Laboratoire de charme value: Positive
Generated Narrative: Observation b4916505-a06b-460c-9be8-011609282457-with-immunization status: Final category: Laboratory code: E Ab [Presence] in Serum or Plasma subject: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) effective: 2015-10-10 09:35:00+0100 performer: Organization Laboratoire de charme value: Positive
Generated Narrative: Observation a6a5a1d5-c896-4c7e-b922-888fcc7e6ae4-with-immunization status: Final category: Laboratory code: little c Ab [Presence] in Serum or Plasma subject: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) effective: 2015-10-10 09:35:00+0100 performer: Organization Laboratoire de charme value: Negative
little c Ab [Presence] in Serum or Plasma
Generated Narrative: Observation 2639657a-c19a-48e2-82cc-471e13b8ad94-with-immunization status: Final category: Laboratory code: Blood typing subject: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) effective: 2015-10-10 performer: Organization Laboratoire de charme hasMember: Observation ABO and Rh group [Type] in Blood Observation C Ab [Presence] in Serum or Plasma Observation E Ab [Presence] in Serum or Plasma Observation little c Ab [Presence] in Serum or Plasma
Generated Narrative: Observation cc354e00-a419-47ea-8b6c-1768b2a01646-with-immunization status: Final category: Laboratory code: Hemoglobin A1c/Hemoglobin.total in Blood by HPLC subject: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) effective: 2017-11-10 08:20:00+0100 performer: Organization Laboratoire de charme value: 7.5 % (Details: UCUM code% = '%') note: Above stated goal of 7.0 %
Hemoglobin A1c/Hemoglobin.total in Blood by HPLC
Generated Narrative: Observation 26bee0a9-5997-4557-ab9d-c6adbb05b572-with-immunization status: Final category: Laboratory code: Bacteria identified in Isolate subject: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) effective: 2017-12-10 08:20:00+0100 performer: Organization Laboratoire de charme value: Methicillin resistant Staphylococcus aureus note: Healthy carrier of MRSA
Methicillin resistant Staphylococcus aureus
Generated Narrative: AllergyIntolerance c7781f44-6df8-4a8b-9e06-0b34263a47c5-with-immunization clinicalStatus: Active code: No known food allergy (situation) patient: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583)
Generated Narrative: Immunization 40b7b6a0-c043-423a-9959-be3707e728b2 Language: fr-LU status: Completed vaccineCode: Vaccin anti diphtérie-coqueluche-tétanos-poliomyélite patient: Martha DeLarosa Female, DoB: 1972-05-01 ( urn:oid:2.16.840.1.113883.2.4.6.3#574687583) occurrence: 1998-06-04 00:00:00+0200 primarySource: true lotNumber: AXK23RWERS expirationDate: 2000-06-01 site: Cuisse droite route: Voie intramusculaire ProtocolApplieds - TargetDisease DoseNumber[x] * Pertussis 1
Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens only vaccine product
Vaccin anti diphtérie-coqueluche-tétanos-poliomyélite
DIPHTERIE - COQUELUCHE - POLIOMYELITE - TETANOS
Diphtheria caused by Corynebacterium diphtheriae